Trial Profile

A phase 3 study of efficacy and safety of ketamine in Post traumatic stress disorders patients

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 20 Feb 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ketamine-topical-formulation-Psycheceutical (Primary)
Indications Post-traumatic stress disorders
Focus Adverse reactions; Registrational; Therapeutic Use

Most Recent Events

20 Feb 2023 New trial record
16 Feb 2023 According to a Psycheceutical media release, on the basis of phase 2 study the company will proceed directly to a Phase III clinical trial rather than an additional Phase IIb clinical trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com